Skip to content
Business Times – Lifestyle
Author:
Likang Life Sciences
ESMO 2026 | Professors Jie Wang, Zhijie Wang and Jianchun Duan’s Team Reports 95.2% Disease Control With LK101 Combination Maintenance Therapy in Advanced NSCLC
October 25, 2026
Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026
October 24, 2026
Likang Life Sciences to Showcase Advances in Personalized Cancer Immunotherapy at Abu Dhabi Future Health Summit 2026
October 13, 2026
China’s Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a “DeepSeek Moment”?
August 29, 2026